CD4 and COVID-19: Taken together, despite strong lymphopenia affecting both CD4+ and CD8+ T cells, and lower levels of polyclonal SEB-reactive CD4+ T cells, patients with severe COVID-19 were capable of mounting high levels of SARS-CoV-2–specific T cells.